BSB
INDP icon

Bangor Savings Bank’s Indaptus Therapeutics INDP Stock Holding History

Bangor Savings Bank’s Portfolio INDP Stock Details INDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13
Closed -$192 – 544
2025
Q1 		$192 Sell
13
-1
-7% -$23 ﹤0.01% 534
2024
Q4 		$337 Hold
14
– – ﹤0.01% 545
2024
Q3 		$496 Hold
14
– – ﹤0.01% 533
2024
Q2 		$848 Hold
14
– – ﹤0.01% 496
2024
Q1 		$896 Hold
14
– – ﹤0.01% 487
2023
Q4 		$704 Hold
14
– – ﹤0.01% 498
2023
Q3 		$1.1K Hold
14
– – ﹤0.01% 508
2023
Q2 		$764 Hold
14
– – ﹤0.01% 520
2023
Q1 		$740 Hold
14
– – ﹤0.01% 523
2022
Q4 		$1K Hold
14
– – ﹤0.01% 512
2022
Q3 		$1K Buy
+14
New +$1.09K ﹤0.01% 512

Other funds holding INDP

SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bangor Savings Bank's INDP Position: Q2 2025 in Review

Bangor Savings Bank sold out of Indaptus Therapeutics (INDP) in Q2 2025, closing a stake of 13 shares — an estimated $192 sold.

Bangor Savings Bank first reported a position in INDP in Q3 2022 and held it in 11 quarters. The position peaked at $1.1K in Q3 2023. 5 funds tracked by Wall St. Rank hold INDP as of Q2 2025.

  • Bangor Savings Bank reported no remaining Indaptus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Bangor Savings Bank sold 13 Indaptus Therapeutics shares in Q2 2025, an estimated $192.
  • Bangor Savings Bank first reported a position in Indaptus Therapeutics in Q3 2022 and held it in 11 quarters.
  • Bangor Savings Bank's Indaptus Therapeutics position peaked at $1.1K in Q3 2023.
  • 5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2025.

Based on Bangor Savings Bank's 13F filing for Q2 2025, filed 7 Jul 2025.